<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-vaccines-08-00197">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kazaks</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Lu</surname>
    <given-names>I.-N.</given-names>
   </name>
   <name>
    <surname>Farinelle</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Ramirez</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Crescente</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Blaha</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Ogonah</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Mukhopadhyay</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>de Obanos</surname>
    <given-names>M.P.</given-names>
   </name>
   <name>
    <surname>Krimer</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Production and purification of chimeric HBc virus-like particles carrying influenza virus LAH domain as vaccine candidates</article-title>
  <source>BMC Biotechnol.</source>
  <year>2017</year>
  <volume>17</volume>
  <elocation-id>79</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12896-017-0396-8</pub-id>
  <pub-id pub-id-type="pmid">29126399</pub-id>
 </element-citation>
</ref>
